Prognostic value of neurohumoral activation in patients with an acute myocardial infarction: effect of captopril. - Wikidata - awgldk - TriplyDB

Prognostic value of neurohumoral activation in patients with an acute myocardial infarction: effect of captopril.

Prognostic value of neurohumoral activation in patients with an acute myocardial infarction: effect of captopril.

http://www.wikidata.org/entity/Q34059547

about

Science review: natriuretic peptides in critical illness Reducing cardiorenal risk through combination therapy with a direct renin inhibitor Early neurohormonal effects of trandolapril in patients with left ventricular dysfunction and a recent acute myocardial infarction: a double-blind, randomized, placebo-controlled multicentre study.Aliskiren and valsartan combination therapy for the management of hypertension.Measurement of the renin-angiotensin system in heart failure.The natriuretic peptides: physiology and role in left-ventricular dysfunction.Cardiac natriuretic peptides--hope or hype?The impact of cardiac natriuretic peptide determination on the diagnosis and management of heart failure.Adrenal beta-arrestin 1 inhibition in vivo attenuates post-myocardial infarction progression to heart failure and adverse remodeling via reduction of circulating aldosterone levels.Direct inhibition of renin: a physiological approach to treat hypertension and cardiovascular disease.New developments in the pharmacological treatment of chronic heart failure.Inhibitory-excitatory synaptic balance is shifted toward increased excitation in magnocellular neurosecretory cells of heart failure rats.Long term biventricular resynchronisation therapy in advanced heart failure: effect on neurohormones Neuroendocrine-autonomic integration in the paraventricular nucleus: novel roles for dendritically released neuropeptides.Vasopressin receptor antagonists in the management of acute heart failure.Altered astrocyte glutamate transporter regulation of hypothalamic neurosecretory neurons in heart failure rats.Angiotensin receptor blockers: therapeutic targets and cardiovascular protection.Conivaptan: a selective vasopressin antagonist for the treatment of heart failure.Tolvaptan: a selective vasopressin type 2 receptor antagonist in congestive heart failure.Plasma aldosterone levels are elevated in patients with pulmonary arterial hypertension in the absence of left ventricular heart failure: a pilot study Conivaptan: a step forward in the treatment of hyponatremia?Plasma cardiac natriuretic peptide determination as a screening test for the detection of patients with mild left ventricular impairment.A Functional Coupling Between Carbon Monoxide and Nitric Oxide Contributes to Increased Vasopressin Neuronal Activity in Heart Failure rats.Role of tolvaptan in acute decompensated heart failure.Association of arginine vasopressin levels with outcomes and the effect of V2 blockade in patients hospitalized for heart failure with reduced ejection fraction: insights from the EVEREST trial Enhanced NMDA receptor-mediated intracellular calcium signaling in magnocellular neurosecretory neurons in heart failure rats.Emerging diuretics for the treatment of heart failure.Plasma renin activity and risk of cardiovascular and mortality outcomes among individuals with elevated and nonelevated blood pressure Sympathetic neural activity in hypertension and related diseases.Conivaptan: Evidence supporting its therapeutic use in hyponatremia.Significance of hyponatremia in heart failure.Renin-angiotensin-aldosterone system blockade in high-risk hypertensive patients: current approaches and future trends.New roles for renin and prorenin in heart failure and cardiorenal crosstalk.The role of direct renin inhibition in clinical practice: focus on combination therapy.Mineralocorticoid receptor activation in myocardial infarction and failure: recent advances.Total cardiovascular risk, blood pressure variability and adrenergic overdrive in hypertension: evidence, mechanisms and clinical implications.Plasma renin and cardiovascular risk: what is the evidence for an association?Role of the sympathetic nervous system in hypertension and hypertension-related cardiovascular disease.Aldosterone Does Not Predict Cardiovascular Events Following Acute Coronary Syndrome in Patients Initially Without Heart Failure.Steroidal and Novel Non-steroidal Mineralocorticoid Receptor Antagonists in Heart Failure and Cardiorenal Diseases: Comparison at Bench and Bedside.

P2860

Q24799740-BC68C3B5-C03D-4F35-8651-7CCA8F4A90FD Q26851307-48D12F61-1DE5-4111-BE20-72E9E6A62BAF Q31863980-131E23DF-5AFD-40BE-9F14-5F643A7F3C64 Q34139070-7F49A91A-74D4-4645-A2EB-15A2E0698280 Q34170513-152573DC-E04F-4E55-BF51-777782835A64 Q34171357-EC8D4DCF-3D41-410B-92D9-6C2FDAE72C89 Q34207401-96D6E480-A840-4CE5-B46A-52374D15B1B8 Q34346282-7DE29933-840B-404D-8A04-19A849A417C5 Q34925428-CAC1FD61-E24B-4FB2-B7BD-C596EBF1D400 Q35000118-B22D1FF6-BB01-4E47-9B1D-5387BB35F6F2 Q35117060-094A3093-6ECC-44EB-BB5E-F578C6BCBD6C Q35217638-10568976-18A5-424D-82A2-F37AB9912533 Q35584155-9F54C902-F195-4ECB-8C8D-BE4C3DB1F58E Q35661185-A6ED5B4E-6DD0-418E-B4C0-55451A4031E3 Q36145836-F5BFB974-E5AA-4C1D-B00E-C2D4807CE742 Q36178516-A3285870-73AD-4A51-AC8F-E0BA6DBFCB62 Q36242608-B4E80CFD-5923-4528-8245-147A7FBECBC1 Q36351998-EF3312B7-9CD9-48DB-8EFB-884209304620 Q36458380-C3F0CE7E-2CE2-41B0-B291-AF5B7E7164D4 Q36623035-6F1F64B2-6D30-4507-83B4-9BFCC975A674 Q36823541-4C93DCDD-51D8-46A6-AA30-76EADA759200 Q36835952-3D98D9BB-E5EE-4A0D-9E6C-C755EDD1E41B Q36911576-C654C984-E7E7-4381-9A97-C250CF7BCD71 Q37176415-6919F17B-171C-4B5B-A443-AC374370C207 Q37214187-E52A630E-CFBA-4B3E-A998-901DECA83E21 Q37323514-2F72399E-9FFA-4401-99EE-4889C1A3FEA8 Q37386310-0584EAB2-D43D-4887-A2A7-DA24171AFB6A Q37480881-83C722A0-D9F9-4809-BDB3-61CE0AF1D1B9 Q37774849-E3A41113-0855-4361-BD4B-7142CE3B45A2 Q37778737-9AB416B3-F381-4C7B-B97F-10FAA380AABA Q37788586-F4CF7184-86A8-41B7-BE1A-C920F226C46E Q37802083-A8843E01-0FC3-4697-89E1-10F0364FC84F Q37893014-1F77BEBE-9613-4E33-B2B9-17818AB19315 Q37918526-CF876987-E294-4017-9059-D11821AF20D7 Q38005732-16F674CC-29D4-49CC-81CF-9D7498E66DE3 Q38007091-449C51D6-F8BB-4165-8469-7C5E0669BB67 Q38103400-E979C684-587C-4472-8241-852673650A75 Q38208753-2A3FB102-BC96-46F2-8AD6-F8047B9B601D Q38382574-AFC6A4D9-58B1-4745-98DE-29238F6E261B Q39199991-B20E21A6-4615-42B2-80B2-5647EF5A56CC

P2860

Prognostic value of neurohumoral activation in patients with an acute myocardial infarction: effect of captopril.

http://www.wikidata.org/entity/Q34059547

description

1994 nî lūn-bûn

@nan

1994 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

1994 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

1994年の論文

@ja

1994年論文

@yue

1994年論文

@zh-hant

1994年論文

@zh-hk

1994年論文

@zh-mo

1994年論文

@zh-tw

1994年论文

@wuu

name

Prognostic value of neurohumor ...... farction: effect of captopril.

@ast

Prognostic value of neurohumor ...... farction: effect of captopril.

@en

Prognostic value of neurohumor ...... farction: effect of captopril.

@nl

type

label

Prognostic value of neurohumor ...... farction: effect of captopril.

@ast

Prognostic value of neurohumor ...... farction: effect of captopril.

@en

Prognostic value of neurohumor ...... farction: effect of captopril.

@nl

prefLabel

Prognostic value of neurohumor ...... farction: effect of captopril.

@ast

Prognostic value of neurohumor ...... farction: effect of captopril.

@en

Prognostic value of neurohumor ...... farction: effect of captopril.

@nl

P1433

Q34059547-B7082869-E8DD-48F6-AB61-78E21B7A2508

P1476

Q34059547-DE75953A-75EA-485B-A24F-135917E0FEA0

P2093

Q34059547-0FF3B1AB-EDE5-4FA2-9718-934A7011CD19

Q34059547-18437A55-DF27-4B29-8FC5-444F9AC14FFF

Q34059547-336A4320-BF8E-4C4F-8F47-D879F5643C57

Q34059547-5B699DB2-7D0C-4EF6-AF1D-D1265DDD2FA7

Q34059547-8EF4328B-4AE7-4885-92D3-C42403EDFF42

Q34059547-9EA83CD9-0A5F-4F73-858A-0DB07C187BEE

Q34059547-A27052DC-9956-4509-A67D-FA670A396A2C

Q34059547-A7229761-2E4A-4D15-BCBD-387A05F2A412

Q34059547-DE41D364-8482-49E9-8F1A-A05C1BB3CD17

Q34059547-F316BCEC-F260-457B-B9EE-08C1F5F98191

P304

Q34059547-89657740-77B4-43D7-950C-9B05FE495A52

P31

Q34059547-ACA9DE0F-6DD7-4E70-8A77-D4F8B914212F

P356

Q34059547-7FA0AB74-F19C-4CB2-8D96-00D4EE851BDA

P407

Q34059547-59C5F4F9-ADA8-4A70-AD31-D0E3C468DEB6

P433

Q34059547-AD26A1D4-44D9-47A1-8498-E8C08B42B0FE

P478

Q34059547-6A3E3AD9-618F-474B-AFC3-0AAAA34B15DB

P577

Q34059547-9B03BD44-0820-4F14-8467-A0B9B2636892

P5875

Q34059547-1F6A8043-F623-4B24-8BBA-86EBB5D701C8

P698

Q34059547-32B8C1CD-27EC-4858-AF84-3FACADF392F2

P921

Q34059547-0A5782FE-0C02-419A-B2F4-FDEAD801D843

Q34059547-D2AFBEFD-8964-463E-9B4C-BF819690A143

P356

0735-1097(94)90001-9

P1433

Journal of the American College of Cardiology

P1476

Prognostic value of neurohumor ...... farction: effect of captopril.

@en

P2093

Arnold JM

http://www.w3.org/2001/XMLSchema#string

Bichet D

http://www.w3.org/2001/XMLSchema#string

Klein M

http://www.w3.org/2001/XMLSchema#string

Moyé L

http://www.w3.org/2001/XMLSchema#string

Packer M

http://www.w3.org/2001/XMLSchema#string

Rouleau JL

http://www.w3.org/2001/XMLSchema#string

Rouleau JR

http://www.w3.org/2001/XMLSchema#string

Sestier F

http://www.w3.org/2001/XMLSchema#string

Sussex B

http://www.w3.org/2001/XMLSchema#string

de Champlain J

http://www.w3.org/2001/XMLSchema#string

P304

583-591

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/0735-1097(94)90001-9

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

24

http://www.w3.org/2001/XMLSchema#string

P577

1994-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

223706740

http://www.w3.org/2001/XMLSchema#string

P698

7915733

http://www.w3.org/2001/XMLSchema#string

P921